Portfolio (Quarterly)
Guide ↗
Defilade Capital Management, L.P.
· CIK 0002088557| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | EVMN | EVOMMUNE INC | Healthcare | 678,589.0 | $15.6M | 2.19% | +463K | +215.0% | $22.99 | -4.8% |
| 22 | TNDM | TANDEM DIABETES CARE INC | Healthcare | 761,905.0 | $14.6M | 2.05% | NEW | — | $19.17 | -29.4% |
| 23 | COGT | COGENT BIOSCIENCES INC | Healthcare | 352,590.0 | $13.6M | 1.91% | -216K | -38.0% | $38.49 | -18.5% |
| 24 | NUVL | NUVALENT INC | Healthcare | 129,950.0 | $13.3M | 1.87% | -139K | -51.7% | $102.45 | -2.5% |
| 25 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 1,487,645.0 | $12.6M | 1.77% | +806K | +118.2% | $8.47 | -1.1% |
| 26 | — | ASCENDIS PHARMA A/S | — | 51,895.0 | $11.9M | 1.67% | -34K | -39.4% | $228.73 | — |
| 27 | ALGN | ALIGN TECHNOLOGY INC | Healthcare | 67,332.0 | $11.5M | 1.62% | -61K | -47.4% | $171.43 | -9.5% |
| 28 | ELDN | ELEDON PHARMACEUTICALS INC | Healthcare | 3,564,127.0 | $11.0M | 1.54% | +274K | +8.3% | $3.08 | +16.2% |
| 29 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 842,928.0 | $10.7M | 1.50% | NEW | — | $12.67 | -37.4% |
| 30 | — | BIOHAVEN LTD | — | 315,944.0 | $2.7M | 0.38% | NEW | — | $8.46 | — |
| 31 | MREO | MEREO BIOPHARMA GROUP PLC | Healthcare | 7,558,756.0 | $2.5M | 0.35% | NEW | — | $0.33 | -27.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.2%
Financial Services
3.8%